admedicum Patient Driven Solutions

Enhancing Decision-Making with Patient Preference Information

How patient preference research supported shared decision-making and informed regulatory and HTA-relevant evidence in benign prostatic hyperplasia (BPH).

Clinical Research & Development Through Patient Partnership

The impact of patient-relevant engagement to raise awareness and drive recruitment in a phase II clinical trial.

Embedded Expert Support for Patient Engagement

Interim patient engagement support to strengthen patient community relationships, advance a disease‑specific digital platform, and provide flexible ad‑hoc project assistance.

Patient Experience Data on Health Care Gaps

Capturing the lived burden of NTM-LD (Nontuberculous Mycobacterial Lung Disease) across Europe to generate evidence that will help improve diagnosis, care, and outcomes.

Patient-led Education and Awareness Campaign

Supporting the German patient-driven initiative "Hepatitis-freies Köln" to improve early diagnosis and care for people living with hepatitis through collaboration with industry and health care partners.

Patient Group Training on Marketing Authorization and HTA

Building the knowledge and confidence patients need to participate meaningfully in regulatory and market access decisions.

Clinical Research & Development Through Patient Partnership

The impact of patient-relevant engagement to raise awareness and drive recruitment in a phase II clinical trial.

Patient Experience Data on Health Care Gaps

Capturing the lived burden of NTM-LD (Nontuberculous Mycobacterial Lung Disease) across Europe to generate evidence that will help improve diagnosis, care, and outcomes.

Clinical Research & Development Through Patient Partnership

The impact of patient-relevant engagement to raise awareness and drive recruitment in a phase II clinical trial.

Patient Experience Data on Health Care Gaps

Capturing the lived burden of NTM-LD (Nontuberculous Mycobacterial Lung Disease) across Europe to generate evidence that will help improve diagnosis, care, and outcomes.

Enhancing Decision-Making with Patient Preference Information

How patient preference research supported shared decision-making and informed regulatory and HTA-relevant evidence in benign prostatic hyperplasia (BPH).

Patient Experience Data on Health Care Gaps

Capturing the lived burden of NTM-LD (Nontuberculous Mycobacterial Lung Disease) across Europe to generate evidence that will help improve diagnosis, care, and outcomes.

Patient Group Training on Marketing Authorization and HTA

Building the knowledge and confidence patients need to participate meaningfully in regulatory and market access decisions.

Enhancing Decision-Making with Patient Preference Information

How patient preference research supported shared decision-making and informed regulatory and HTA-relevant evidence in benign prostatic hyperplasia (BPH).

Embedded Expert Support for Patient Engagement

Interim patient engagement support to strengthen patient community relationships, advance a disease‑specific digital platform, and provide flexible ad‑hoc project assistance.

Patient Experience Data on Health Care Gaps

Capturing the lived burden of NTM-LD (Nontuberculous Mycobacterial Lung Disease) across Europe to generate evidence that will help improve diagnosis, care, and outcomes.

Patient-led Education and Awareness Campaign

Enhancing Decision-Making with Patient Preference Information

How patient preference research supported shared decision-making and informed regulatory and HTA-relevant evidence in benign prostatic hyperplasia (BPH).

Clinical Research & Development Through Patient Partnership

The impact of patient-relevant engagement to raise awareness and drive recruitment in a phase II clinical trial.

Embedded Expert Support for Patient Engagement

Interim patient engagement support to strengthen patient community relationships, advance a disease‑specific digital platform, and provide flexible ad‑hoc project assistance.

Patient Experience Data on Health Care Gaps

Capturing the lived burden of NTM-LD (Nontuberculous Mycobacterial Lung Disease) across Europe to generate evidence that will help improve diagnosis, care, and outcomes.

Patient-led Education and Awareness Campaign

Patient Group Training on Marketing Authorization and HTA

Building the knowledge and confidence patients need to participate meaningfully in regulatory and market access decisions.

Genuine Collaborations Drive Concrete Impact